EPO and anemia (phenotype): Indeed, in spite of the normal endogenous EPO levels that were similar to those of the control group, the 200 IU rHuEPO group developed anemia, suggesting that the anti-rHuEPO antibodies also neutralized the action of endogenous EPO.